These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells. Taylor MA; Amin JD; Kirschmann DA; Schiemann WP Neoplasia; 2011 May; 13(5):406-18. PubMed ID: 21532881 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Wendt MK; Schiemann WP Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433 [TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971 [TBL] [Abstract][Full Text] [Related]
11. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560 [TBL] [Abstract][Full Text] [Related]
12. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis. Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532 [TBL] [Abstract][Full Text] [Related]
13. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Vasiljeva O; Papazoglou A; Krüger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T Cancer Res; 2006 May; 66(10):5242-50. PubMed ID: 16707449 [TBL] [Abstract][Full Text] [Related]
15. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer. Guillory B; Sakwe AM; Saria M; Thompson P; Adhiambo C; Koumangoye R; Ballard B; Binhazim A; Cone C; Jahanen-Dechent W; Ochieng J Am J Pathol; 2010 Nov; 177(5):2635-44. PubMed ID: 20847285 [TBL] [Abstract][Full Text] [Related]
16. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629 [TBL] [Abstract][Full Text] [Related]
17. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. Grum-Schwensen B; Klingelhöfer J; Grigorian M; Almholt K; Nielsen BS; Lukanidin E; Ambartsumian N Cancer Res; 2010 Feb; 70(3):936-47. PubMed ID: 20103644 [TBL] [Abstract][Full Text] [Related]